Effect of Preoperative Information About Pain on Postoperative Pain Experience and Patient Satisfaction (epps)
Effect of Preoperative Information About Pain on Postoperative Pain Experience and Patient Satisfaction in Adult Elective Orthopedic Patients: A Randomized Controlled Trial
Patients are randomized into 2 groups. The intervention group which receives preoperative counseling about pain and a control group which does not receive this counseling.
The patients are followed up looking at pain scores and pain experience and satisfaction with pain management for 2 days post operative.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
- All patients admitted for elective upper and lower limb surgery, will be expected to have a preoperative visit by the anesthetic provider on the day before surgery.
- Those who will have consented to participate in the study will be randomized to either the intervention or control group.
- The intervention group will receive specific preoperative information about pain in private by the principal investigator in addition to the preoperative assessment.
- The following variables will be recorded preoperatively: socio-demographics (age, gender, tribe, education level) and vital signs (pulse rate, blood pressure and oxygen saturation).
- A Numerical pain score will be explained to patient before it is recorded preoperatively.
- The patient will also be informed that the pain scores will be repeated after surgery at (someone will take the pain scores again after surgery at) 0, 6, 12, 24, 48hours or till discharge if less than 48hours. In addition the pulse rate, number of analgesic intravenous/ intramuscular injections or tablets needed/or given will be recorded.
- Assessed pain will be classified as no pain (1-3), pain (4-10) but also as no pain (0), mild (1-3), moderate (4-6) and severe pain (7-10).
- Intra operatively, the anaesthetic technique (general or regional), medications given, duration of surgery will be recorded in) the questionnaires.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Moses Othin
- Phone Number: +256 753 020430
- Email: othinm@gmail.com
Study Contact Backup
- Name: Claire Lubulwa
- Phone Number: +256 782 444854
- Email: lubulwac@gmail.com
Study Locations
-
-
-
Kampala, Uganda, +256
- Recruiting
- Mulago National Referral Hospital
-
Contact:
- Claire Lubulwa
- Phone Number: +256 782 444854
- Email: lubulwac@gmail.com
-
Contact:
- Mark Kasumba
- Phone Number: +256 793 625678
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age of 18 years and above
- Elective orthopedic surgery patients admitted to orthopedic/trauma ward Mulago hospital
- Patient who gives consent
Exclusion Criteria:
- Patients with chronic pain not related to the surgery they are to undergo
- Patients with bone cancer
- Inability to speak or hear (deaf or dumb)
- Previously recruited but comes for re-surgery for same condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Info
In this arm the patients are counseled preoperatively about post operative pain. Specific information about post operative pain which includes both pharmacologic and non-pharmacologic treatments, complications of pain and benefits of good pain management. This is in addition to the routine care provided |
It is information about analgesics, post operative pain, complications of pain, benefits of pain treatment and non pharmacologic treatment options.
|
|
No Intervention: No info
These patients are in the control group.
They are left to receive only the routine preoperative care as made available to them while on ward.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post operative pain experience (yes or no answer)
Time Frame: 2 days
|
Patients subjectively tell you if their pain has been adequately controlled with a yes or no answer
|
2 days
|
|
Patient satisfaction (answer yes or no)
Time Frame: 2 days
|
Is the patient happy with how the pain has been managed answer yes or no
|
2 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to ambulation
Time Frame: 3 days
|
when does the patient start doing some activity with the operated limb less than or greater than 3 days
|
3 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Moses Othin, Makerere University College of Health Sciences
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2014/HD07/939U
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.